SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $63,000 | +250.0% | 5,618 | +246.4% | 0.00% | – |
| Q2 2017 | $18,000 | +12.5% | 1,622 | +1.4% | 0.00% | – |
| Q1 2017 | $16,000 | -61.0% | 1,600 | -58.2% | 0.00% | – |
| Q4 2016 | $41,000 | +156.2% | 3,832 | +136.1% | 0.00% | – |
| Q3 2016 | $16,000 | -27.3% | 1,623 | -4.5% | 0.00% | – |
| Q2 2016 | $22,000 | -8.3% | 1,700 | -22.7% | 0.00% | – |
| Q1 2016 | $24,000 | -91.9% | 2,200 | -93.2% | 0.00% | – |
| Q4 2015 | $297,000 | +1385.0% | 32,285 | +981.9% | 0.00% | – |
| Q3 2015 | $20,000 | -95.9% | 2,984 | -94.0% | 0.00% | – |
| Q2 2015 | $487,000 | +14.1% | 49,679 | +3.2% | 0.00% | – |
| Q1 2015 | $427,000 | +2568.8% | 48,147 | +2574.8% | 0.00% | – |
| Q4 2014 | $16,000 | +14.3% | 1,800 | -10.0% | 0.00% | – |
| Q3 2014 | $14,000 | -22.2% | 2,000 | -42.9% | 0.00% | – |
| Q2 2014 | $18,000 | +63.6% | 3,500 | +40.0% | 0.00% | – |
| Q1 2014 | $11,000 | +120.0% | 2,500 | +150.0% | 0.00% | – |
| Q4 2013 | $5,000 | -95.2% | 1,000 | -95.2% | 0.00% | – |
| Q3 2013 | $105,000 | +1650.0% | 20,688 | +1508.7% | 0.00% | – |
| Q2 2013 | $6,000 | – | 1,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,552,482 | $13,755,000 | 2.96% |
| Nantahala Capital Management | 1,522,625 | $13,490,000 | 2.24% |
| GLOBEFLEX CAPITAL L P | 150,138 | $1,330,000 | 0.25% |
| Ativo Capital Management LLC | 71,563 | $634,000 | 0.25% |
| MCKINLEY CAPITAL MANAGEMENT LLC | 543,110 | $4,812,000 | 0.19% |
| RFG Advisory, LLC | 24,700 | $208,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 345,833 | $3,064,000 | 0.12% |
| Spark Investment Management LLC | 95,900 | $849,000 | 0.12% |
| Numeric Investors LLC | 1,002,814 | $8,885,000 | 0.11% |
| ClariVest Asset Management LLC | 384,222 | $3,404,000 | 0.10% |